IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells.
Fischer S, Weber LM, Stielow B, Frech M, Simon C, Geller M, Könnecke J, Finkernagel F, Forné I, Nist A, Bauer UM, Stiewe T, Neubauer A, Liefke R.
Fischer S, et al. Among authors: simon c.
Nucleic Acids Res. 2024 May 27:gkae437. doi: 10.1093/nar/gkae437. Online ahead of print.
Nucleic Acids Res. 2024.
PMID: 38801077